SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-17-010319
Filing Date
2017-05-30
Accepted
2017-05-30 17:14:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A dffn20170530_s3a.htm S-3/A 1337470
2 EXHIBIT 23.1 ex23-1.htm EX-23.1 4227
3 dffn20170516_s3img003.jpg GRAPHIC 10370
  Complete submission text file 0001437749-17-010319.txt   1357414
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-218062 | Film No.: 17878420
SIC: 2834 Pharmaceutical Preparations